M

Welcome to the Brand page for “M”, which is offered here for Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies for others;the mark consists of the letter m in green stylized font.;pharmaceutical and medicinal preparations and substances, human vaccines, therapeutic proteins and antibodies for treatment of infectious diseases, chronic diseases and cancer;medicago;the color(s) green is/are claimed as a feature of the mark.;research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; medical and scientific research regarding clinical trial studies on new vaccine candidates; development of pharmaceuticals, pharmaceutical ingredients, vaccines, and antibodies;.

Its status is currently believed to be active. Its class is unavailable. “M” is believed to be currently owned by “Medicago Inc.”

Owner:
MEDICAGO INC.
Owner Details
Description:
Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies for others;The mark consists of the letter M in green stylized font.;Pharmaceutical and medicinal preparations and substances, human vaccines, therapeutic proteins and antibodies for treatment of infectious diseases, chronic diseases and cancer;MEDICAGO;The color(s) green is/are claimed as a feature of the mark.;Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; medical and scientific research regarding clinical trial studies on new vaccine candidates; development of pharmaceuticals, pharmaceutical ingredients, vaccines, and antibodies;
Categories: MANUFACTURE PHARMACEUTICALS